Mir-1203 is involved in hepatocellular carcinoma metastases and indicates a poor prognosis

14Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Non-coding RNAs, especially miRNAs, have been shown to be important regulators in multiple human diseases, including malignant tumors, congenital disease, and autoimmune disease. In this study, we screened the metastasis-associ-ated miRNAs in hepatocellular carcinoma (HCC). Based on the miRNA microarray screening, miR-1203 was confirmed to be the most significant miRNA and was also highly associated with HCC metastases. Bioinformatics prediction indicated direct binding of miR-1203 in SOCS3, which was also confirmed by a dual luciferase reporter assay, resulting in suppres-sion of SOCS3. Increased miR-1203 also promoted invasion of HCC cells through suppressing SOCS3, while no effect on cell proliferation or apoptosis was detected. Circulating expression of miR-1203 and SOCS3 might serve as a predictor of metastases and poor prognosis in HCC patients. In conclusion, miR-1203 might promote HCC metastasis by decreasing SOCS3. MiR-1203 predicts a poor outcome in HCC patients and thus might serve as a potential therapeutic target for the prevention of HCC.

Author supplied keywords

Cite

CITATION STYLE

APA

Shi, J., Li, X., Hu, Y., Zhang, F., Lv, X., Zhang, X., … Hu, S. (2020). Mir-1203 is involved in hepatocellular carcinoma metastases and indicates a poor prognosis. Neoplasma, 67(2), 267–276. https://doi.org/10.4149/neo_2019_190414N328

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free